Amanda Lutter, NP
Gerontology · Fort Wayne, INNPI 1912322264
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 171 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 11.7% — the pattern of someone who eats at a lot of different presentations.
Across 171 payments — averaging $17.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$341
- United Therapeutics Corporation$314
- Pfizer$306
- Boehringer Ingelheim$288
- AstraZeneca$226
- Alnylam Pharmaceuticals Inc.$207
- plus $1K from 16 others
What the payments were for
- Food & beverage$2,927100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 20 | $341 |
| United Therapeutics Corporation | 8 | $314 |
| Pfizer | 23 | $306 |
| Boehringer Ingelheim | 20 | $288 |
| AstraZeneca | 15 | $226 |
| Alnylam Pharmaceuticals Inc. | 9 | $207 |
| Johnson & Johnson | 14 | $202 |
| Amgen | 13 | $178 |
| Edwards Lifesciences | 4 | $152 |
| Esperion Therapeutics, Inc. | 11 | $145 |
| Merck | 7 | $118 |
| Actelion Pharmaceuticals US, Inc. | 5 | $97 |
| Abbott | 4 | $84 |
| Bayer | 6 | $84 |
| Amarin Pharma, Inc. | 3 | $53 |
| E.r. Squibb & Sons, L.L.C. | 2 | $29 |
| Kowa Pharmaceuticals America, Inc. | 2 | $28 |
| Boston Scientific | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Chiesi USA, Inc. | 1 | $16 |
| Akcea Therapeutics, Inc. | 1 | $13 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TYVASO$125
How this compares
$2,927 in reported general payments places this provider in the 85th percentile of 230 gerontology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 43 | $55,081 |
| JardianceEmpagliflozin | 46 | $39,943 |
| EntrestoSacubitril/Valsartan | 30 | $31,130 |
| Ezetimibe | 46 | $810 |
| Metoprolol Succinate | 57 | $603 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 24 | $537 |
| Rosuvastatin Calcium | 52 | $395 |
| Atorvastatin Calcium | 78 | $381 |
| Nebivolol Hcl | 11 | $335 |
| Carvedilol | 58 | $275 |
| Amlodipine Besylate | 64 | $248 |
| Valsartan | 11 | $224 |
| Potassium Chloride | 26 | $206 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 13 | $197 |
| Spironolactone | 24 | $155 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $306 | $55,08143 claims |
| Boehringer IngelheimJardiance | $288 | $39,94346 claims |
| NovartisEntresto | $341 | $31,13030 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 230 gerontology providers in Indiana.
Other gerontology in Fort Wayne
- Mary ParkerFort Wayne$13K
- Marena ArnoldFort Wayne$8K
- Nikki MannFort Wayne$4K
- Christopher BowmanFort Wayne$4K
- Joyce NwakanmaFort Wayne$1K
- Angela PattiMunster$44K
- Jessica KiszkaMunster$42K
- Sandra GarofaloIndianapolis$24K
- Megan MonnierBloomington$23K
- Diane BrackinFishers$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.